Drug News

Medindia's Press Release’ section provides the latest press release on Drug from across the world for the global audience. This page links to 12872 Drug press releases.

Everest Medicines' Partner Calliditas Therapeutics Announces Nefecon® the Only FDA-approved Treatment for IgA Nephropathy to Significantly Slow Kidney Function Decline

SHANGHAI , Dec. 20, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company")'s licensing partner Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) ("Calliditas") announced that the U.S. Food and ...


European Commission revokes all centrally granted generic marketing permissions for dimethyl fumarate ('DMF'), including Dimethyl Fumarate Neuraxpharm

Decision is not due to any public health concerns regarding generic DMF products Neuraxpharm to swiftly contest this decision at the General Court of the European Union BARCELONA, Spain and DÜSSELDORF, Germany , Dec. 20, 2023 ...

Liberty Cannabis Somerville Now Open for Adult-Use

Liberty Cannabis Somerville Welcomes New Customers Seeking Recreational Cannabis SOMERVILLE, Mass. , Dec. 18, 2023 /PRNewswire/ -- Liberty Cannabis , the retail arm of Holistic Industries , today announced its Somerville store ...

RNAimmune Receives Investigational New Drug Application Clearance from U.S. FDA for mRNA-Based Respiratory Syncytial Virus Vaccine RV-1770

GERMANTOWN, Md and GUANGZHOU, China , Dec. 18, 2023 /PRNewswire/ -- Sirnaomics Ltd.  (the "Company", Stock Code: 2257, together with its subsidiaries, the "Group" or "Sirnaomics"), a leading biopharmaceutical company engaging in discovery ...

Innoforce's Partner RNAimmune Granted IND Clearance for RSV mRNA Vaccine from FDA

HANGZHOU, China , Dec. 18, 2023 /PRNewswire/ -- RNAimmune, Inc., a partner of Innoforce, announced the U.S. Food and Drug Administration (FDA) granted IND clearance for its RV-1770 Respiratory Syncytial Virus (RSV) mRNA vaccine. Innoforce ...

GeneQuantum and BioMap establish a strategic collaboration to jointly develop a series of next-generation ADC therapeutics

SUZHOU, China , Dec. 17, 2023 /PRNewswire/ -- Recently, GeneQuantum Healthcare (GQ), a global leader in ADC new drug development focused on innovative bioconjugation technologies, and BioMap, a global leader in life science AI Foundation ...

Nona Biosciences Enters into a Global License Agreement with Pfizer for HBM9033, an MSLN-Targeted Antibody-Drug Conjugate (ADC)

Nona Biosciences will receive a total of up to $53 Million in upfront and near-term payments, with the potential for milestones of up to $1.05 billion plus royalties. Pfizer partnership expands Nona's global network of collaborations, ...

Innovent Announces Inclusion in the China National Reimbursement Drug List of TYVYT® 's Seventh Indication and BYVASDA®'s Eighth Indication

ROCKVILLE, Md. and SUZHOU, China , Dec. 12, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the ...

WuXi Vaccines Wins Second Consecutive "Best Vaccine CMO Award" at AVEA 2023

SINGAPORE , Dec. 12 , 2023  /PRNewswire/ -- WuXi Vaccines, a leading global vaccine Contract Development and Manufacturing Organization (CDMO), was named "Best Vaccine CMO of the Year" for the second consecutive year at the 2023 ...

Inner Glow's Sol Defense Gummies Made to Help Protect Consumers from UV Rays

Science-Driven Supplements Founder says they created Sol Defense gummies because the last decade was the hottest on record and patients need additional protection beyond sunscreen CHANTILLY, Va. , Dec. 12, 2023 /PRNewswire/ -- The world ...

Drug News »

Resmetirom For MASH: Approved by US FDA, Increase in Partnerships

Resmetirom For MASH: Approved by US FDA, Increase in Partnerships

Biopharmaceutical companies are once again competing in the development of innovative drugs for metabolic dysfunction-associated steatohepatitis (MASH), after a series of failures faced by drug manufacturers. The US FDA approval of ...

Semaglutide: A Dominant Player for Patients With Heart Failure

Semaglutide: A Dominant Player for Patients With Heart Failure

A study was presented by the Gardy Health system in Atlanta, Georgia, US, at the 73rd Annual Scientific Session of the American College of Cardiology. The study was conducted to evaluate the frequency of heart failure hospitalizations (HFH) in ...

Physician's Lack Agreement – Patients Prefer Branded or Generic Drugs?

Physician's Lack Agreement – Patients Prefer Branded or Generic Drugs?

Generic drugs and Branded drugs are essentially the same, as they both have the same active ingredient. Generic drugs can provide the same therapeutic advantages as branded drugs at a reduced cost, as they do not have to undergo extensive ...

Drug Resistant Melanoma Caused Due to Break in Genes!

Drug Resistant Melanoma Caused Due to Break in Genes!

Melanoma is an extremely fatal form of skin cancer and has inherent resistance to both radiotherapy and chemotherapy ( ). The occurrence of Melanoma has been increasing steadily and become a major health issue since the 5-year ...

Marijuana Use for Morning Sickness Risks Mother and Baby Health

Marijuana Use for Morning Sickness Risks Mother and Baby Health

Using marijuana to alleviate nausea and vomiting during pregnancy could harm newborns’ brain development and exacerbate maternal health issues ...

More Drug News

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.